Cargando…

Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease

Triple negative breast cancer (TNBC) remains challenging because of heterogeneous responses to chemotherapy. Incomplete response is associated with a greater risk of metastatic progression. Therefore, treatments that target chemotherapy-resistant TNBC and enhance chemosensitivity would improve outco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Katsutoshi, Padgaonkar, Amol A., Baker, Stacey J., Cosenza, Stephen C., Rechkoblit, Olga, Subbaiah, D. R. C. Venkata, Domingo-Domenech, Josep, Bartkowski, Alison, Port, Elisa R., Aggarwal, Aneel K., Ramana Reddy, M. V., Irie, Hanna Y., Reddy, E. Premkumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8333338/ https://www.ncbi.nlm.nih.gov/pubmed/34344863 http://dx.doi.org/10.1038/s41467-021-24878-z

Ejemplares similares

Targeting protein kinase CK2 and CDK4/6 pathways with a multi-kinase inhibitor ON108110 suppresses pro-survival signaling and growth in mantle cell lymphoma and T-acute lymphoblastic leukemia
por: Padgaonkar, Amol, et al.
Publicado: (2018)

Discovery of 8-Cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile (7x) as a Potent Inhibitor of Cyclin-Dependent Kinase 4 (CDK4) and AMPK-Related Kinase 5 (ARK5)
por: Reddy, M. V. Ramana, et al.
Publicado: (2014)

Rigosertib ameliorates the effects of oncogenic KRAS signaling in a murine model of myeloproliferative neoplasia
por: Baker, Stacey J., et al.
Publicado: (2019)

Structural Insight into TNIK Inhibition
por: Kukimoto-Niino, Mutsuko, et al.
Publicado: (2022)

Emergence of TNIK inhibitors in cancer therapeutics
por: Yamada, Tesshi, et al.
Publicado: (2017)

Expression analysis of TRAF2‑ and NCK‑interacting protein kinase (TNIK) and phosphorylated TNIK in papillary thyroid carcinoma
por: Li, Jiali, et al.
Publicado: (2023)

TNIK inhibition abrogates colorectal cancer stemness
por: Masuda, Mari, et al.
Publicado: (2016)

Direct conversion of osteosarcoma to adipocytes by targeting TNIK
por: Hirozane, Toru, et al.
Publicado: (2021)

ON01210.Na (Ex-RAD(®)) Mitigates Radiation Damage through Activation of the AKT Pathway
por: Kang, Anthony D., et al.
Publicado: (2013)

The essential role of TNIK gene amplification in gastric cancer growth
por: Yu, D-H, et al.
Publicado: (2014)

The essential role of TNIK gene amplification in gastric cancer growth
por: Yu, D-H, et al.
Publicado: (2014)

TNIK is a conserved regulator of glucose and lipid metabolism in obesity
por: Pham, T. C. Phung, et al.
Publicado: (2023)

Dual Inhibition of CDK4/Rb and PI3K/AKT/mTOR Pathways by ON123300 Induces Synthetic Lethality in Mantle Cell Lymphomas
por: Divakar, Saikrishna A., et al.
Publicado: (2015)

Agonistic and Antagonistic Roles for TNIK and MINK in Non-Canonical and Canonical Wnt Signalling
por: Mikryukov, Alexander, et al.
Publicado: (2012)

Prognostic significance of Traf2- and Nck- interacting kinase (TNIK) in colorectal cancer
por: Takahashi, Hidenori, et al.
Publicado: (2015)

TNIK Inhibition Has Dual Synergistic Effects on Tumor and Associated Immune Cells
por: Kim, Jaehee, et al.
Publicado: (2022)

Rap2 and TNIK control Plexin-dependent tiled synaptic innervation in C. elegans
por: Chen, Xi, et al.
Publicado: (2018)

TNIK signaling imprints CD8(+) T cell memory formation early after priming
por: Jaeger-Ruckstuhl, Carla A., et al.
Publicado: (2020)

Cardioprotective Effects of 6-Gingerol against Alcohol-Induced ROS-Mediated Tissue Injury and Apoptosis in Rats
por: Ganjikunta, Venkata Subbaiah, et al.
Publicado: (2022)

Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target()()
por: Lee, Rachel S, et al.
Publicado: (2019)

Molecular Docking analysis of the TNIK Receptor protein with a potential Inhibitor from the NPACT databas
por: Rosita, Arokiaraj Sherlin, et al.
Publicado: (2020)

Computational study on new natural compound inhibitors of Traf2 and Nck-interacting kinase (TNIK)
por: Ma, Lushun, et al.
Publicado: (2022)

P1343: TNIK SIGNALLING IMPAIRS SELF-RENEWAL AND LONG-TERM RECONSTITUTION CAPACITY OF HSCS
por: Palombella, Luca, et al.
Publicado: (2023)

CDK4: a master regulator of the cell cycle and its role in cancer
por: Baker, Stacey J., et al.
Publicado: (2022)

Identification of TNIK as a novel potential drug target in thyroid cancer based on protein druggability prediction
por: Yang, Yi-Fei, et al.
Publicado: (2021)

De Novo Discovery of Thiopeptide Pseudo-natural Products Acting as Potent and Selective TNIK Kinase Inhibitors
por: Vinogradov, Alexander A., et al.
Publicado: (2022)

Mutational analysis of two residues in the DYRK homology box of the protein kinase DYRK1A
por: Widowati, Esti Wahyu, et al.
Publicado: (2018)

Mechanism of error-free replication across benzo[a]pyrene stereoisomers by Rev1 DNA polymerase
por: Rechkoblit, Olga, et al.
Publicado: (2017)

DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B
por: Yousefelahiyeh, Mina, et al.
Publicado: (2018)

Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B
por: Papenfuss, Marco, et al.
Publicado: (2022)

Disease-associated synaptic scaffold protein CNK2 modulates PSD size and influences localisation of the regulatory kinase TNIK
por: Zieger, Hanna L., et al.
Publicado: (2020)

Deficiency of germinal center kinase TRAF2 and NCK-interacting kinase (TNIK) in B cells does not affect atherosclerosis
por: van Os, Bram W., et al.
Publicado: (2023)

Emerging roles of DYRK2 in cancer
por: Tandon, Vasudha, et al.
Publicado: (2021)

Macro-CK and CK-BB Contributing to Sham CK-MB Elevation
por: Wada, Yuki, et al.
Publicado: (2017)

Silmitasertib (CX-4945), a Clinically Used CK2-Kinase Inhibitor with Additional Effects on GSK3β and DYRK1A Kinases: A Structural Perspective
por: Grygier, Przemyslaw, et al.
Publicado: (2023)

Structural basis for polymerase η–promoted resistance to the anticancer nucleoside analog cytarabine
por: Rechkoblit, Olga, et al.
Publicado: (2018)

Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η
por: Rechkoblit, Olga, et al.
Publicado: (2019)

Structural basis of DNA synthesis opposite 8-oxoguanine by human PrimPol primase-polymerase
por: Rechkoblit, Olga, et al.
Publicado: (2021)

Mini-Implant Assisted Gummy Smile and Deep Bite Correction
por: Reddy, S. B. V. Ramana, et al.
Publicado: (2021)

The Omnipresence of DYRK1A in Human Diseases
por: Deboever, Estelle, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_08fodhd2trgd3rp9utpt1jk7au